Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
12/26/2012 | CN102258492B Neostigmine bromide slow release preparation and its preparation method |
12/26/2012 | CN102247500B External use medicinal ointment for treating anorectal diseases and preparation method thereof |
12/26/2012 | CN102228616B Chinese patent medicine for treating digestive system disease |
12/26/2012 | CN102218132B Medicinal composition for treating nasal bleeding |
12/26/2012 | CN102205085B Anti-ulcer powder for treating stomach disease |
12/26/2012 | CN102205068B Medicament for treating chronic ulcerative colitis and preparation method thereof |
12/26/2012 | CN102188523B Plant antibiotic |
12/26/2012 | CN102138939B Preparation method of asterias amurensis polysaccharide extract and medical applications thereof |
12/26/2012 | CN102119927B Enteric-coated pellet preparation of proton pump inhibitor and preparation method thereof |
12/26/2012 | CN102078028B Cigarette for benefiting gallbladder, reducing blood pressure and giving up smoking and preparation method thereof |
12/26/2012 | CN102048753B Preparation method and applications of Tibetan medical decoction iron powder |
12/26/2012 | CN102038939B Preparation method of adenosine triphosphate coenzyme insulin freeze-dried powder injection |
12/26/2012 | CN102038638B 盐酸克林霉素注射液及其制备方法 Clindamycin Hydrochloride Injection and its preparation method |
12/26/2012 | CN101972220B Medicated toothpaste |
12/26/2012 | CN101953773B Lamivudine liposome solid preparation |
12/26/2012 | CN101863985B Recombinant human fusion Tat cytoglobulin and application thereof in treating liver cancer |
12/26/2012 | CN101844970B Dibenzocyclooctene lignin derivatives with bioactivity |
12/26/2012 | CN101835478B Laxative agent |
12/26/2012 | CN101804047B Antimicrobial and radioprotective compounds |
12/26/2012 | CN101780246B Traditional Chinese medicine composition with function of promoting digestion and preparation method thereof |
12/26/2012 | CN101524377B Composite of wall-breaking lucidum spore powder and cyclodextrin and preparation method thereof |
12/26/2012 | CN101439181B Stable water injection medicament composition containing Ulinastatin |
12/26/2012 | CN101437799B p38 MAP kinase inhibitors |
12/26/2012 | CN101258143B 苄基哌嗪衍生物及其医学用途 Benzyl piperazine derivatives and their medical use |
12/26/2012 | CN101076521B Process for producing muscarine receptor antagonist and intermediate therefor |
12/26/2012 | CN100998864B Cyclosporin A semisolid skeleton capsule |
12/25/2012 | US8338478 Derivatives of 3,3-diphenylpropylamines |
12/25/2012 | US8338385 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor |
12/25/2012 | US8337889 Smectite dispersible tablets and the preparation thereof |
12/25/2012 | US8337886 Pellet formulation for the treatment of the intestinal tract |
12/25/2012 | US8337834 Methods of making enhanced, autologous fat grafts |
12/25/2012 | US8337829 Conditioned medium and proliferated cell lines produced therefrom |
12/20/2012 | WO2012174253A1 Methods for aloe processing |
12/20/2012 | WO2012173464A1 Oral care product for oral hygiene and growth inhibition of microorganisms |
12/20/2012 | WO2012173244A1 Marker for use in detection of periodontopathic bacterium communicable between men and animals |
12/20/2012 | WO2012173219A1 Novel biaryl ether derivative |
12/20/2012 | WO2012173217A1 Crystal of pyrroloquinolinequinone disodium salt, and method for producing same |
12/20/2012 | WO2012173184A1 Lelia (liposome-based enzyme-linked immunoassay) technique using recombinant proteoliposomes |
12/20/2012 | WO2012172635A1 Method for producing anticariogenic composition |
12/20/2012 | WO2012171621A1 Pharmaceutical preparation for treating infections of the intestine with ehec bacteria |
12/20/2012 | WO2012171334A1 Method for transdifferentiating fibroblast into liver stem cell |
12/20/2012 | WO2012171077A1 Method and composition for treatment or inhibition of mucositis associated with chemotherapy or radiation damage |
12/20/2012 | WO2012105798A3 Composition containing chlorogenic acid for preventing or treating gastroesophageal reflux disease |
12/20/2012 | US20120322854 Regulation of macrophage activation using mir-125b |
12/20/2012 | US20120322853 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene |
12/20/2012 | US20120322851 Oral delivery of therapeutically effective lna oligonucleotides |
12/20/2012 | US20120322843 Genotype specific methods for treating human subjects using 4-methylpyrazole |
12/20/2012 | US20120322842 Heterocycyl-substituted-alkylaminophenyl derivatives, their preparation and use as medicaments |
12/20/2012 | US20120322837 Amide compound and medicinal use thereof |
12/20/2012 | US20120322822 Composition containing cinchonine as an active ingredient for preventing and treating obesity, dyslipidemia, fatty liver, or insulin resistance syndrome |
12/20/2012 | US20120322815 Pharmaceutical composition containing a3 adenosine receptor agonist |
12/20/2012 | US20120322814 Methods of inhibiting ire1 |
12/20/2012 | US20120322809 Substituted oxindole derivatives and their use as vasopressin receptor ligands |
12/20/2012 | US20120322801 Heterocyclic amides as rock inhibitors |
12/20/2012 | US20120322793 Protein kinase inhibitors |
12/20/2012 | US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists |
12/20/2012 | US20120322773 Materials and methods for treatment of disorders associated with oxidative stress |
12/20/2012 | US20120322757 Methods for Aloe Processing |
12/20/2012 | US20120322754 Novel use for scopolin and derivatives thereof |
12/20/2012 | US20120322740 Mu opioid receptor agonist analogs of the endomorphins |
12/20/2012 | US20120322729 High activity growth factor mutants |
12/20/2012 | US20120322723 Use of interleukin-1 receptor antagonist for preparing medicament for preventing or treating epithelium trauma of intestinal mucosa |
12/20/2012 | US20120322719 Methods of treatment of fatty liver disease by pharmacological activation of cholinergic pathways |
12/20/2012 | US20120321710 Controlled Release and Taste Masking Oral Pharmaceutical Composition |
12/20/2012 | US20120321702 Pharmaceutical composition of lansoprazole |
12/20/2012 | US20120321693 Prg4 treatment for interstitial cystitis |
12/20/2012 | US20120321685 Compositions containing oils having a specific gravity higher than the specific gravity of water |
12/20/2012 | US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE |
12/20/2012 | US20120321651 Anti-IGE Vaccines |
12/20/2012 | US20120321629 Stem cell factor inhibitor |
12/20/2012 | US20120321600 Infant formula with probiotics and milk fat globule membrane components |
12/20/2012 | US20120321556 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma |
12/20/2012 | US20120321552 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
12/20/2012 | CA2841416A1 Method of selecting therapeutic indications |
12/19/2012 | EP2535413A2 Splice switching oligomers for the TNF superfamily receptors and their use in treatment of disease |
12/19/2012 | EP2535330A2 Iminopyridine derivative and use thereof |
12/19/2012 | EP2535051A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
12/19/2012 | EP2533803A1 Lactocepins for use in the treatment of ip-10-mediated inflammatory diseases |
12/19/2012 | EP2533801A1 Bacterial deoxyribonuclease compounds and methods for biofilm disruption and prevention |
12/19/2012 | EP2533794A1 Protein domains and uses therefor |
12/19/2012 | EP2533786A2 Methods and compositions to improve mechanical resistance of teeth |
12/19/2012 | CN202605099U Moxibustion paster |
12/19/2012 | CN102827737A Health-care wine for clearing liver and improving eyesight |
12/19/2012 | CN102827735A Health-care wine for enriching blood, relaxing bowel, reducing phlegm and depressing blood-fat |
12/19/2012 | CN102827288A Acid-activated CSP targeted antimicrobial peptide and preparation method and applications thereof |
12/19/2012 | CN102827280A Anti-IL-13 antibodies and use thereof |
12/19/2012 | CN102827269A Thymulin alpha 1 analog and preparation method thereof |
12/19/2012 | CN102827265A Novel gene of sorting nexin (SNX) family and use thereof |
12/19/2012 | CN102827257A Peptide fragment of gp96 protein and applications thereof |
12/19/2012 | CN102827253A Micro-molecular polypeptide inhibiting inflammatory response, and application thereof |
12/19/2012 | CN102827246A Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof |
12/19/2012 | CN102827228A Silicon phthalocyanine modified by cytidine derivative and preparation method and application thereof |
12/19/2012 | CN102827227A Silicon phthalocyanine modified by adenosine derivative and preparation method and application thereof |
12/19/2012 | CN102827226A Silicon phthalocyanine modified by uridine derivatives and preparation method and application of silicon phthalocyanine |
12/19/2012 | CN102827206A Pradefovir crystal |
12/19/2012 | CN102827167A Octahydro-pyrrolo[3,4-b]pyrrole derivatives and use of octahydro-pyrrolo[3,4-b]pyrrole derivatives as histamine-3 receptor |
12/19/2012 | CN102827147A Omeprazole sodium crystal compound and medicine composition containing omeprazole sodium crystal compound |
12/19/2012 | CN102827001A Ilex kudingcha C.J.Tseng extract |
12/19/2012 | CN102826752A Bioactive mineral powder containing quasi-nanometer?particles, preparation method and application thereof in dental treatment |
12/19/2012 | CN102824646A Conjugate of polyethylene glycol interferon |